Skip to main content

Table 5 Prediction of HFNC success based on ROX and ROX-HR cut offs at different time points

From: Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate

 

Sensitivity (%)

Specificity (%)

PPV (%)

NPV (%)

LR+

LR−

A. Prediction of HFNC success for patients initiated on HFNC for acute respiratory failure

2-h ROX-HR > 6.80

55.56

74.41

73.17

57.14

2.17

0.60

2-h ROX > 5.80

61.11

67.44

70.21

58.00

1.87

0.58

6-h ROX-HR > 6.80

70.00

57.14

70.00

57.14

1.63

0.53

6-h ROX > 5.80

74.00

57.14

71.15

60.60

1.73

0.46

10-h ROX-HR > 6.80

78.26

58.62

75.00

62.96

1.89

0.37

10-h ROX > 5.80

78.26

58.62

75.00

62.96

1.89

0.37

18-h ROX-HR > 6.80

80.00

55.00

78.05

57.89

1.78

0.36

18-h ROX > 5.80

87.50

35.00

72.92

58.33

1.35

0.36

24-h ROX-HR > 6.80

81.82

64.29

84.39

60.00

2.29

0.28

24-h ROX > 5.80

84.85

57.14

82.35

61.54

1.98

0.27

B. Prediction of HFNC success for patients initiated on HFNC after a planned extubation

2-h ROX-HR > 8.00

82.10

40.00

71.90

54.50

1.37

0.45

2-h ROX > 7.00

78.60

40.00

71.00

50.00

1.31

0.54

6-h ROX-HR > 8.00

74.10

63.60

83.30

50.00

2.04

0.41

6-h ROX > 7.00

74.10

54.50

80.00

46.20

1.63

0.48

10-h ROX-HR > 8.00

84.60

63.60

84.60

63.60

2.32

0.24

10-h ROX > 7.00

84.60

54.50

81.50

60.00

1.86

0.28

18-h ROX-HR > 8.00

82.60

30.00

73.10

42.90

1.18

0.58

18-h ROX > 7.00

78.30

40.00

75.00

44.40

1.31

0.54

24-h ROX-HR > 8.00

66.70

66.70

82.40

46.20

2.00

0.50

24-h ROX > 7.00

71.40

77.80

88.20

53.80

3.22

0.37

  1. HFNC high flow nasal cannula therapy, PPV positive predictive value, NPV negative predictive value, LR likelihood ratio